Boston Scientific falls over 3% on weak guidance despite revenue beat
Published . Updated .
This report does not map to a usual set of affected companies.
Directly affected
- BSX Boston Scientific+2.6% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Boston Scientific belongs to, so it often moves with news about it.
- SYK Stryker+5.8% 30d
Stryker is a peer of Boston Scientific in surgical and medical instruments and apparatus; rivals often move on the same news.
- MMM 3M+0.8% 30d
3M is a peer of Boston Scientific in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+8.5% 30d
Becton, Dickinson and is a peer of Boston Scientific in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline-11.5% 9d
Medline is a peer of Boston Scientific in surgical and medical instruments and apparatus; rivals often move on the same news.
- RMD ResMed+9.8% 30d
ResMed is a peer of Boston Scientific in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BSX | -1.26% | +1.31% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| SYKNo price data for this ticker | — | — | — | — | — | — | — |
| MMMNo price data for this ticker | — | — | — | — | — | — | — |
| BDXNo price data for this ticker | — | — | — | — | — | — | — |
| MDLNNo price data for this ticker | — | — | — | — | — | — | — |
| RMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Boston Scientific falls over 3% on weak guidance despite revenue beat Investing.com
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| BSX | three days earlier | +1.31% | final price |
| BSX | five days earlier | -1.26% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 49 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 54 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 55 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 47 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Becton Dickinson (BDX), worth $100,001 - $250,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Resmed (RMD) (held by a dependent child), worth $1,001 - $15,000 on 11 Sep 2026. That is 47 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, sold Resmed (RMD), worth $15,001 - $50,000 on 26 Aug 2026. That is 63 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Boston Scientific falls over 3% on weak guidance despite revenue beat” scores 12 out of 100. The score uses 1 sources.